The Hemoglobinopathies - PowerPoint PPT Presentation

1 / 53
About This Presentation
Title:

The Hemoglobinopathies

Description:

Methemoglobinemia (Hemoglobin M) Introduction to Methemoglobinemia ... Three causes of methemoglobinemia: Hemoglobin M variants (dominant inheritance) ... – PowerPoint PPT presentation

Number of Views:1193
Avg rating:3.0/5.0
Slides: 54
Provided by: terryj1
Category:

less

Transcript and Presenter's Notes

Title: The Hemoglobinopathies


1
Chapter 11
  • The Hemoglobinopathies

2
1. Study Questions2. Homework Assignment3.
Exam for Unit 1
3
The Hemoglobinopathies
  • In Chapter 11 you will be introduced to the
    various hemoglobinopathies.  You will learn about
    the pathophysiology, clinical signs and symptoms,
    laboratory test results, and treatments for these
    disorders.  Be sure you learn the peripheral
    blood characteristics that make each
    hemoglobinopathy unique.  Also, remember which
    amino acid substitution creates which abnormal
    hemoglobin.

4
Introduction to Hemoglobinopathies
5
Introduction to Hemoglobinopathies1 of 3
  • Qualitative abnormalities in globin structure,
    usually involving beta-chain.
  • Most arise from single amino acid substitution. 
    Example is substitution of valine for glutamic
    acid in sixth position of beta chain producing
    Hemoglobin S (sickle cell anemia).
  • Rarely see multiple substitutions.
  • May or may not cause abnormal laboratory test
    results.

6
Introduction to Hemoglobinopathies2 of 3
  • Hemoglobin variant abnormal hemoglobin caused
    by abnormal globin chain structure.
  • Hemoglobinopathy condition produced by
    hemoglobin variant. Confirmed by lab tests.
  • Qualitative globin chain abnormality amino acid
    sequence wrong.
  • Quantity of hemoglobin produced normal.

7
Introduction to Hemoglobinopathies3 of 3
  • Most hemoglobinopathies caused by single point
    change in amino acid sequence in globin chain. 
    Abnormalities caused by 
  • Substitution
  • Deletion
  • Addition
  • Hb variants follow Mendelian genetics.

8
Broad Classification System for Hemoglobin
Disorders
  • Qualitative
  • Hemoglobins differ in sequence of amino acids
    composing globin chain. 
  • Disorders called hemoglobinopathies.
  • Quantitative
  • Characterized by decreased production of
    hemoglobin resulting from decreased synthesis of
    one particular globin chain. 
  • Called thalassemia  (Chapter 12).

9
Better Classification System has Five Categories
  • 1. Abnormal hemoglobins without clinical
    significance.
  • 2. Aggregating hemoglobins (sickle cell anemia).
  • 3. Unbalanced synthesis of hemoglobin
    (thalassemia).
  • 4. Unstable hemoglobins.
  • 5. Hemoglobins with abnormal heme function.

10
Nomenclature
  • Began by using letters of alphabet, soon ran out
    of letters.
  • Changed to using names of places. Use
    combination of letter plus a place name. For
    Example, HbCHarlem.
  • Description of variant can include chains and
    substitution. For example, homozygous Hb S is
    a2ß2S or a2ß26Val or a2ß26Glu-Val.

11
Laboratory Tests and Findings
  • Laboratory findings are variable.  Depends upon
    which hemoglobinopathy is being tested.
  • Tests include
  • CBC
  • Sickle Cell Screening (Dithionite Test)
  • Hemoglobin Electrophoresis
  • Supravital stains for Heinz bodies
  • Hb F and Hb A2 quantitation

12
Dithionite Test for Sickle Cell
  • Screening test for Sickle Cell Disease
  • Fast
  • Cheap
  • Fairly accurate
  • Procedure
  • RBCs are lysed by saponin.
  • Sodium dithionite binds and removes O2.
  • HbS precipitates out.
  • Solution becomes turbid. 

13
Hemoglobin Electrophoresis
  • Use EDTA whole blood.  Make a hemolysate by
    lysing RBCs.
  • Cellulose acetate is support medium.
  • Perform electrophoresis using buffer at pH 8.4.
  • Stain is Ponseau S.
  • Confirm with citrate agar electrophoresis at
    acidic pH.
  • Textbook page 174

14
Alkali Denaturation Test for Fetal Hemoglobin
  • HbF resists denaturation by alkali.
  • Spectrophotometric analysis.
  • Calculated as total hemoglobin.
  • Use whole blood EDTA. 
  • Hemoglobin F less than 1 after 1 year of age.

15
Sickle Cell Anemia and Sickle Cell Trait
16
Introduction to Sickle Cell Anemia
  • Is worldwide disorder.
  • Autosomal co-dominant Both Hemoglobin A and
    Hemoglobin S produced.
  • AS is sickle cell trait.
  • SS is sickle cell disease.  Patient is homozygous
    for HbS (SS).  Results in very severe anemia.
  • Probably originated in Africa.
  • Hb S is point mutation for sixth amino acid in
    Beta chain. Valine substituted for glutamic
    acid. One benefit for AS persons is increased
    resistance to malaria.

17
Incidence of Sickle Cell Disease
  • 1 of 375 African-American live births have
    hemoglobin SS (Sickle Cell Disease) Have 85
    chance to live to age 20.
  • 8-10 of American blacks carry the Hb S trait
    (heterozygous).
  • Affects more than 50,000 Americans.
  • In Africa, half of infants with sickle cell
    disease die in the first year of life.

18
Pathophysiology of Sickle Cell Anemia 1 of 5
  • SS cells may look normal when fully oxygenated
    Sickling occurs when O2 decreased.
  • Other causes of sickling include decrease in pH
    and dehydration of patient.
  • Cells become rigid, impeding blood flow to
    tissues. Tissue death, organ infarction, and
    pain result. 
  • Sickling is reversible up to a point.
  • Have both extravascular hemolysis and
    intravascular hemolysis.

19
Pathophysiology of Sickle Cell Anemia 2 of 5
  • Usually diagnosed early in life.
  • Have all physical symptoms of anemia.
  • Growth and sexual maturation slower.
  • Crisis very painful. Anything that
    deoxygenates blood acts as trigger (exercise,
    illness and airplane flights). Sickle cells get
    stuck in capillaries.

20
Pathophysiology of Sickle Cell Anemia 3 of 5
  • Have three types of crises
  • Aplastic crisis  associated with infections
    which causes temporary suppression of
    erythropoiesis.
  • Hemolytic crisis  Results in exaggerated anemia.
  • Vaso-occlusive crisis  Associated with severe
    pain.  Is hallmark symptom of sickle cell anemia.

21
Pathophysiology of Sickle Cell Anemia 4 of 5
  • Hands and feet swell (dactylitis), fingers grow
    at different rates.
  • Joint pain in arms and legs first. May affect
    lungs.  Have chest pain and abdominal pain.
  • Spleen enlarges cells become trapped. Have
    decreased blood volume (hypovolemia), and shock.
    Repeated splenic infarcts cause splenic
    dysfunction, increasing susceptibility to
    infection.

22
Pathophysiology of Sickle Cell Anemia 5 of 5
  • Organs Affected
  • Liver Enlarges, malfunctions, jaundice,
    hyperbilirubinemia.
  • Heart  Cardiomegaly, iron deposits.
  • Spleen  Enlarges leading to infarction and
    fibrosis. Eventually shrivels and becomes
    nonfunctional.
  • Skin Develop ulcers.
  • Kidney  Hematuria and eventual failure.
  • Lungs Infarction.
  • Brain  Strokes.

23
Peripheral Blood Findingsin Sickle Cell Anemia
  • Hb 6-8 g/dL severe anemia.
  • Marked aniso and poik.
  • Sickle cells and Target cells.
  • Ovalocytes and Schistocytes.
  • NRBCs with Polychromasia.
  • Increased Retics.
  • Basophilic Stippling.
  • Howell Jolly Bodies and Pappenheimer Bodies.
  • Leukocytosis with left shift and Thrombocytosis.

24
Special Hematology Tests in Sickle Cell Anemia
  • Electrophoresis Hb S present.
  • Sickling Test Positive.
  • Osmotic Fragility Decreased.
  • Sed Rate Decreased.

25
Chemistry Testsin Sickle Cell Anemia
  • LDH increased.
  • Bilirubin Indirect and total both increased.
  • Haptoglobin decreased.

26
Treatment and Prognosis for Sickle Cell Anemia
  • Improving.
  • Prevent crisis.
  • If crisis keep hydrated.   Alleviate pain.
  • Treat infections with antibiotics.  Keep warm. 
    Blood transfusion if needed.
  • Prophylactic penicillin treatment prevents most
    deaths due to pneumococcal infections.
  • RBC exchanges are beneficial.
  • Developing anti-sickling agents (hydroxyurea)
    which increases amount of Hemoglobin F in red
    cells.  Decreases amount of sickling that occurs
    during crisis.
  • Bone marrow transplants in children show promise.
  • Future treatment may include gene therapy.

27
Sickle Cell Trait
  • Heterozygous AS with more HbA than HbS, so
    condition is compensated for.
  • Normal life, except if have severe hypoxia or
    respiratory infection.
  • Patient often has normal life span.

28
Laboratory Findings in Sickle Cell Trait
  • Normal CBC Few target cells or sickle cells may
    be present.
  • Sickle solubility test positive.
  • Electrophoresis Both A and S present.

29
Hemoglobin C Disease
30
Introduction to Hb C Disease
  • Amino acid substitution of lysine for glutamic
    acid at sixth position of Beta chain
    (a2ß26Glu-Lys).
  • Is homozygous CC. 
  • HbC crystals on peripheral blood.
  • Second most common variant after HbS.
  • Found almost exclusively in Black population.
  • Chronic hemolytic anemia with associated
    splenomegaly and abdominal discomfort.

31
Laboratory Findings in Hb C Disease
  • Mild to moderate anemia (8-12 g/dL), splenomegaly
    and abdominal discomfort.
  • Numerous target cells, few microspherocytes,
    schistocytes, and folded cells.
  • May see hexagonal or rod-shaped crystals ("bar of
    gold).  Usually intracellular. Are elongated
    with blunt ends and parallel sides.
  • Retic count 4-8 (slightly increased).
  • Electrophoresis Most hemoglobin is HbC no HbA
    present may or may not have increase in Hb F.

32
Hemoglobin C Trait (AC)
  • No symptoms no anemia. 
  • Target cells frequent finding.

33
Treatment for Hb C
  • Splenectomy may be beneficial for symptomatic CC
    homozygous persons.
  • AC heterozygous persons are usually asymptomatic,
    so no treatment required.

34
Hemoglobin D Disease
35
Hb D Disease
  • Homozygous and heterozygous forms.
  • Migrates with HbS upon electrophoresis, but does
    not cause sickling of RBCs.
  • Many variants All are rare forms.
  • Both heterozygous and homozygous states are
    asymptomatic.
  • No clinical (physical) abnormalities.

36
Hemoglobin E Disease
37
Hb E Disease
  • ß chain variant lysine substituted for glutamic
    acid in 26th position in beta chain
    (a2ß226Glu-Lys).
  • Heterozygous and homozygous forms.
  • Third most common variant of hemoglobin. Occurs
    with greatest frequency in Southeast Asia.
  • Frequently occurs with Beta thalassemia.
  • No clinical symptoms.

38
Laboratory Findings in Hb E Disease
  • Similar to Hb D.
  • Mild, microcytic, hypochromic hemolytic anemia.
  • Many target cells.
  • Electrophoresis shows E band. Normal Hb F, no Hb
    A.
  • May protect against malaria.

39
Hemoglobin SC Disease and Other Combinations
40
Introduction to Hb SC Disease and other
Combinations
  • May have combinations of abnormal hemoglobins.
  • Occurs when have HbS gene from one parent and HbC
    gene from other parent (Hb SC).
  • 1 in 835 American blacks have sickle C disease
    (SC).
  • Patients generally less anemic and better
    prognosis than SS patients.

41
Laboratory Findings in SC Disease
  • Sickle cell symptoms including splenomegaly.
  • Positive for anemia.  Mild if present.
  • See target cells, folded, pocket-book cells, and
    rare sickle cells  Washington monument"
    crystals (fingerlike projections) may be found.
  • Positive sickle solubility test.
  • Electrophoresis shows equal amounts of HbC and
    HbS, no HbA. Hb F normal or elevated.

42
Other Combinations of Abnormal Hemoglobins
  • May find HbS in combination with other abnormal
    hemoglobins, such as Hb SD. 
  • Hb SD Disease has positive solubility test. 
    Severity of disease between Hb SS and Hb SA.
  • May find combination of hemoglobinopathy and
    thalassemia (Hb S/ß Thalassemia).
  • Can make differentiation difficult.

43
Hemoglobins with Increased Oxygen Affinity
44
Hb with Increased Oxygen Affinity
  • Decreased delivery of oxygen to tissues.
  • Hb values from normal to 20 g/dL.
  • Leukocytes and platelets normal.
  • Normal life span.
  • No treatment.
  • Often results in polycythemia.

45
Hemoglobins with Decreased Oxygen Affinity
46
Hemoglobins with Decreased Oxygen Affinity
  • Increased release of oxygen to tissues.
  • Patient may become anemic.

47
Unstable Hemoglobin Disease
48
Introduction to Unstable Hemoglobin Diseases
1 of 2
  • More than 180 unstable hemoglobins have been
    described, but most are not associated with
    hemolysis.
  • Unstable hemoglobins are hemoglobin variants in
    which amino acid substitutions or deletions have
    weakened the binding forces that maintain the
    structure of the molecule.
  • Instability may cause Hb to denature and
    precipitate in the red cells as Heinz bodies.

49
Introduction to Unstable Hemoglobin Diseases
2 of 2
  • Most inherited as autosomal dominant disorders.
  • When anemia is present, degree of hemolysis
    varies considerably
  • Most have mild compensated anemia with mild
    reticulocytosis
  • Some have severe, chronic hemolysis with
    splenomegaly and jaundice.
  • Hb electrophoresis usually not very helpful in
    diagnosis. Isopropanol precipitation or heat
    denaturation tests are used to detect unstable Hb.

50
Special Diagnostic Tests
  • Isopropanol Precipitation
  • Unstable Hemoglobins precipitate out within 5
    minutes.
  • Normal Hemoglobins do not precipitate.
  • Heat Denaturation Test
  • Washed red cells hemolyzed with H20.  Incubate. 
    Will denature hemoglobin.  See precipitation.
    Normal Hemoglobins do not precipitate.
  • Heinz Body Staining
  • Supravital staining. Brilliant Cresyl Blue
    Stain. Heinz bodies stain pale blue and are
    refractile. Eccentrically located.

51
Methemoglobinemia (Hemoglobin M)
52
Introduction to Methemoglobinemia
  • Clinical condition with methemoglobin levels
    greater than 1 of total Hgb.
  • HbM contains ferric iron (Fe3) Cant carry
    oxygen and results in cyanosis.
  • Three causes of methemoglobinemia
  • Hemoglobin M variants (dominant inheritance)
  • NADH-diaphorase deficiency (recessive
    inheritance)
  • Toxic substance (acquired)

53
Hb M
  • 5 variants of Hb M which result from single amino
    acid substitution in the globin chain that
    stabilizes iron in the ferric form.
  • Patients have cyanosis, but are otherwise
    asymptomatic and no treatment is given.

54
Laboratory Findings in Hb M
  • Blood is chocolate brown.
  • Mild hemolytic anemia.
  • Heinz bodies.
  • M band on electrophoresis.
Write a Comment
User Comments (0)
About PowerShow.com